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Genome mining in amycolatopsis balhimycina for ferredoxins
capable of supporting cytochrome P450 enzymes involved in
glycopeptide antibiotic biosynthesis
Abstract
Ferredoxins are required to supply electrons to the cytochrome P450 enzymes involved in cross-linking
reactions during the biosynthesis of the glycopeptide antibiotics balhimycin and vancomycin. However,
the biosynthetic gene clusters for these antibiotics contain no ferredoxin- or ferredoxin reductase-like
genes. In a search for potential ferredoxin partners for these P450s, we report here an in silico analysis
of the draft genome sequence of the balhimycin producer Amycolatopsis balhimycina, which revealed
11 putative Fe-S-containing ferredoxin genes. We show that two members (balFd-V and balFd-VII),
produced as native-like holo-[3Fe-4S] ferredoxins in E. coli, could supply electrons to the P450 OxyB
(CYP165B) from both A. balhimycina and the vancomycin producer A. orientalis, and support in vitro
turnover of peptidyl carrier protein-bound peptide substrates into monocyclic cross-linked products.
These results show that ferredoxins encoded in the antibiotic-producing strain can act in a degenerate
manner in supporting the catalytic functions of glycopeptide biosynthetic P450 enzymes from the same
as well as heterologous gene clusters.
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Abstract 
Ferredoxins are required to supply electrons to the cytochrome P450 enzymes involved in 
cross-linking reactions during the biosynthesis of the glycopeptide antibiotics balhimycin and 
vancomycin. However, the biosynthetic gene clusters for these antibiotics contain no 
ferredoxin- or ferredoxin reductase-like genes. In a search for potential ferredoxin partners 
for these P450s, we report here an in silico analysis of the draft genome sequence of the 
balhimycin producer Amycolatopsis balhimycina, which revealed 11 putative Fe-S-containing 
ferredoxin genes. We show that two members (balFd-V and balFd-VII), produced as native-
like holo-[3Fe-4S] ferredoxins in E. coli, could supply electrons to the P450 OxyB 
(CYP165B) from both A. balhimycina and the vancomycin producer A. orientalis, and 
support in vitro turnover of peptidyl carrier protein-bound peptide substrates into monocyclic 
cross-linked products. These results show that ferredoxins encoded in the antibiotic-
producing strain can act in a degenerate manner in supporting the catalytic functions of 
glycopeptide biosynthetic P450 enzymes from the same as well as heterologous gene clusters. 
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Introduction 
Cytochrome P450 enzymes typically catalyze the hydroxylation of substrates, using 
molecular oxygen and reducing equivalents supplied by NAD(P)H. The class I bacterial 
cytochrome P450 hydroxylases require a flavin-dependent ferredoxin reductase (FdR), which 
is reduced by NAD(P)H, and a ferredoxin (Fd) iron-sulfur protein to mediate electron transfer 
to the P450 heme (Munro et al., 2007). Less well studied is a small group of P450s that 
catalyze oxidative phenol coupling reactions on substrates containing phenolic groups (Isin & 
Guengerich, 2007). Molecular oxygen is again required, but no oxygen atom is incorporated 
into the product of the enzymic reaction, although there is again a requirement for electrons, 
which must be shuttled from NAD(P)H to the heme during the catalytic cycle. 
 Three bacterial class I cytochrome P450 enzymes called OxyA, OxyB and OxyC 
catalyze three key cross-linking reactions in the biosynthesis of glycopeptide antibiotics of 
the vancomycin/balhimycin family (Fig. 1). X-ray crystal structures of OxyB and OxyC from 
the vancomycin producer Amycolatopsis orientalis confirmed that each contains a typical 
P450 fold, with a conserved cysteine residue acting as proximal axial ligand for the heme 
(Pylypenko et al., 2003; Zerbe et al., 2002). The order of the cross-linking reactions in 
balhimycin biosynthesis has been defined through gene inactivation experiments in A. 
balhimycina (Bischoff et al., 2005; Bischoff et al., 2001a; Bischoff et al., 2001b; Süssmuth et 
al., 1999). The first cross-link, introduced by OxyB, is an aryl-ether bridge (C-O-D ring) 
between the side chains of residues-4 and -6. The second cross-link (D-O-E ring) is 
introduced by OxyA, and the final biaryl link (the AB ring) is created by OxyC. In vitro 
experiments have shown that linear hexa- or heptapeptides attached as C-terminal thioesters 
to the pantetheinyl group of a peptide carrier protein (PCP) domain from the glycopeptide 
non-ribosomal peptide synthetase (NRPS), are the preferred substrates for OxyB (Woithe et 
al., 2007; Zerbe et al., 2004). The first cross-link, therefore, is introduced whilst the peptide 
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chain of the antibiotic is still attached to the NRPS assembly line. So far, in vitro assays with 
the two remaining cross-linking enzymes OxyA and OxyC have not been reported, so the 
timing of these cross-linking steps remains undefined. One complicating factor for in vitro 
assays is that the natural electron transfer proteins for all three P450s have to date not been 
defined. The glycopeptide antibiotic gene clusters reported for balhimycin, 
chloroeremomycin, A40926, A47934 and teicoplanin, do not contain Fd or FdR genes 
(Donadio et al., 2005). Only the biosynthetic gene cluster for the related natural product 
complestatin contains a single Fd gene (comK) (Chiu et al., 2001). 
 To advance in vitro studies of the cross-linking steps in glycopeptide antibiotic 
biosynthesis, we present efforts to identify and characterize Fd genes in the balhimycin 
producer A. balhimycina. The sequencing and annotation of the entire genome is currently 
underway. We describe in silico analyses, which reveal 11 different Fd genes in A. 
balhimycina. Furthermore, we demonstrate the production and purification of two of the 
newly identified Fds, as well as their ability to participate in electron transfers to OxyB from 
both A. balhimycina and A. orientalis. 
 
Materials and methods 
Bioinformatic analyses 
The A. balhimycina DSM5908 genome was analyzed using a BLAST search carried out with 
six Fd sequences (NP-631171, NP-629284, NP-631715, NP-625075, NP-628054, NP-
625924) from S. coelicolor A3(2) (Chun et al., 2007; Lamb et al., 2002), putidaredoxin 
(P00259) from P. putida (Peterson et al., 1990; Pochapsky et al., 1994; Sevrioukova et al., 
2003), and the putative ferredoxin comFd (AAK81833) from the complestatin producer 
S. lavendulae (Chiu et al., 2001). 11 putative Fds, named balFd-I to balFd-XI, containing 
expect (E)-values lower than 10-6, were identified in the whole genome of A. balhimycina 
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(Table 1). Assignment of the iron-sulfur cluster type was achieved through a BLAST search 
of the non-redundant database and a comparison to known Fds. The sequences of the 
ferredoxins balFd-I - balFd-XI have been deposited in the EMBL database under the 
accession numbers FN594523-FN594533. 
 
Cloning, expression and purification of recombinant A. balhimycina ferredoxins  
The genomic DNA of A. balhimycina DSM5908 was used as a PCR template to amplify the 
genes coding for the putative [3Fe-4S] ferredoxins balFd-V and balFd-VII. The primers used 
are shown below (restriction sites underlined):  
5’-balFd-V:  5’-TAGACCATATGAAGGTTGTTGTCGACG-3’  
3’-balFd-V:  5’-ATCTACTCGAGGGCCTCTTCGAGGGC-3’ 
5’-balFd-VII:  5’-TAGACCATATGAAGGTCACCGTGGACG-3’ 
3’-balFd-VII:  5’-ATCTACTCGAGCGCGTCCTCGCTCACCG-3’ 
After digestion with NdeI and XhoI, the fragments were cloned between the NdeI / XhoI sites 
of plasmid pET22b (Novagen) for expression as C-terminal His6-tagged fusion proteins. The 
nt sequence of each insert was confirmed by sequencing. 
 For production in E. coli Rosetta2(DE3)pLysS (balFd-V) or Origami2(DE3) (balFd-
VII), terrific broth medium (400 ml) supplemented with antibiotics and FeSO4 (0.5 mM) was 
induced with isopropyl-β-D-thiogalactopyranoside (0.2 mM), and shaking at 30°C for 6 h. 
Cell pellets in buffer-A (25 ml, 50 mM sodium phosphate pH 7.4, 300 mM KCl, 1 mM 
dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 0.05 % 2-
mercaptoethanol, 5 % glycerol) were disrupted by sonication and the cell debris was removed 
by centrifugation. The supernatant was loaded onto a Ni-nitrilotriacetic acid (NTA) column 
(10 ml) in buffer-B (50 mM sodium phosphate, pH 7.4, 300 mM KCl, 20 mM imidazole). 
After washing, C-terminal His6-tagged proteins were eluted with buffer-C (50 mM sodium 
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phosphate, pH 7.4, 300 mM KCl, 300 mM imidazole). The brown ferredoxins were dialysed 
against Tris/HCl buffer (50 mM, pH 7.5, 1 mM EDTA, 20 % glycerol) and concentrated by 
ultrafiltration (3 kDa cut off, Millipore). Size exclusion chromatography (Superdex 75 10/300 
GL, GE Healthcare) was carried out eluting with Tris/HCl buffer (50 mM, pH 7.5, 1 mM 
EDTA, 20 % glycerol). The purified proteins showed a single band by SDS-PAGE and gave 
a MALDI-MS corresponding to the His6-tagged proteins with loss of the [3Fe-4S] cluster 
(balFd-V: m/z = 7826 [M+H]+, calc. 7826.6, balFd-VII: m/z = 7897 [M+H]+, calc. 7896.6). 
The amounts of iron and acid labile sulfide per balFd-V and balFd-VII were determined 
following published procedures (Beinert, 1983; Fish, 1988). The iron content was also 
determined by atomic adsorption spectroscopy (AAS). 
 Spinach Fd (spinFd), E. coli FdR (ecoFdR) and flavodoxin (ecoFld) were produced, 
following methods described earlier (Woithe et al., 2007). 
 
Production of P450s  
The production and characterization of P450s followed methods described earlier (Woithe et 
al., 2007; Zerbe et al., 2002). Each purified protein showed a single band of ca. 45 kDa by 
SDS-PAGE, and gave an electrospray MS spectrum consistent with the expected protein 
sequence minus the N-terminal methionine residue (data not shown). Furthermore, the UV-
Vis spectrum of each P450 showed a Soret peak at 420±1 nm and α/ß bands around 569/537 
nm. 
 
CO-binding assays  
Assays contained P450 (10 µM), NADPH (0.5 mM), glucose-6-phosphate (0.5 mM), 
glucose-6-phosphate dehydrogenase (0.5 U) in Tris-HCl buffer (50 mM, pH 7.5), with 
ecoFdR (20 µM) and one of: A, spinFd (10 µM); B, ecoFld (10 µM); C, balFd-V (10 µM); D, 
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balFd-VII (10 µM)). The solution was divided between two cuvettes and CO was bubbled 
through the sample cuvette for 20 s. Difference spectra were recorded from 600 nm to 
350 nm over 120 min. 
 
Activity assays  
Production and purification of apo-PCP, and the synthesis of peptide-PCP conjugates (1 and 
2, Fig. 1), was as described previously (Woithe et al., 2007). The assay, containing P450 (5 –
 10 µM), reduction system (Fd or ecoFld (10 µM), ecoFdR (20 µM)), NADPH (1 mM), 
glucose-6-phosphate (1 mM), glucose-6-phosphate dehydrogenase (0.5 U) and PCP-bound 
substrate (50 - 100 µM) in Tris/HCl buffer (1 mL, 50 mM, pH 7.5), was incubated at 30°C 
for 60 min. Protein was precipitated with 1/10 volume of trichloroacetic acid (TCA) (6 M) 
and the resulting pellet was resuspended in 400 µL Tris/HCl buffer (50 mM, pH 7.5) 
containing 2.5 % v/v hydrazine. After incubation at 30°C for 30 min the proteins were 
precipitated with TCA and separated from the supernatant containing the peptide hydrazides, 
which were analyzed by analytical reverse-phase HPLC (Agilent Zorbax Eclipse XDB (RP 
C18, 250 x 4.6 mm, 5 µM particle, 80 Å)) using a gradient of 5-40 % MeCN/0.1 % TFA in 
water/0.1 % TFA over 8 column volumes with a flow rate of 1 mL/min. 
 
Results and Discussion 
In silico analysis of A. balhimycina genome for ferredoxins 
Fds are typically small acidic proteins containing one or two [Fe-S] clusters. The three most 
common clusters found in one-electron transfer reactions are [2Fe-2S], [3Fe-4S] and [4Fe-
4S]. A family of 7Fe Fds found in bacteria contains both [3Fe-4S] and [4Fe-4S] clusters 
within the same polypeptide chain (Meyer, 2008). The draft genome of A. balhimycina 
DSM5908 was analyzed in silico for putative Fds. Table 1 summarizes the 11 newly 
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identified putative Fds from A. balhimycina, which were named balFd-I to balFd-XI (Palmer 
& Reedijk, 1991). 
 Sequence analyses of balFd-I and balFd-II indicate high sequence homologies (56 – 
84 % identity) towards the family of 7Fe Fds (Fig. 2A), including FdxA from Mycobacterium 
smegmatis, whose crystal structure reveals one [3Fe-4S] and one [4Fe-4S] cluster (Ricagno et 
al., 2007). The seven Cys residues that bind the [3Fe-4S][4Fe-4S] clusters in FdxA from M. 
smegmatis are strictly conserved in balFd-I and -II. In vitro activity for the 7Fe Fd from S. 
griseus has been demonstrated with P450soy (Trower et al., 1990). 
 Eight putative Fds (balFd-III to balFd-IX; balFd-XI) show moderate to high sequence 
identities towards a variety of [3Fe-4S] Fds. In these cases, three strictly conserved Cys 
residues are involved in binding the [3Fe-4S] cluster (shown for balFd-V and -VII in Fig. 
2B), which strengthens the assignment of these balFds as [3Fe-4S] Fds. Interestingly, balFd-
IV, -V, -VII and -VIII show high sequence homologies towards Fds that can either be found 
adjacent to a P450 monooxygenase in a biosynthetic gene cluster (NysM (Brautaset et al., 
2000), AmphM (Caffrey et al., 2001) and HbmFdx (Rascher et al., 2005)), or which has been 
shown to co-purify with a P450 enzyme (Fd-2 from S. griseolus (O'Keefe et al., 1991)). 
These results suggest that the newly identified Fds might have a role in supporting the 
activity of P450 enzymes in A. balhimycina. 
 The balFd-X exhibits high sequence similarities toward [2Fe-2S] proteins (Table 1 
and Fig. 2C), in particular, Pdx from P. putida the natural redox partner of P450cam, with 
which it shares a sequence identity of 42% and contains the same four highly conserved 
cysteine residues involved in binding the FeS-cluster (Matsubara & Saeki, 1992). The 
genomes of S. coelicolor A3(2) (Bentley et al., 2002), S. avermitilis (Ikeda et al., 2003), S. 
griseus (Ohnishi et al., 2008), M. tuberculosis (Cole et al., 1998) and Saccharopolyspora 
erythraea (Oliynyk et al., 2007) do not contain proteins with similarities to Pdx or balFd-X. 
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 Shotgun sequencing of the genome of A. balhimycina is finished but manual 
annotation is still ongoing. Most important, no gene encoding a putative Fd can be found 
approximately 360 kbp upstream or downstream of the balhimycin biosynthetic gene cluster. 
However, balFd-V and balFd-VII are each located in close vicinity to other putative P450s, 
as well as FdRs, of unknown function. 
 
Production and characterization of recombinant ferredoxins 
The putative 7Fe Fd balFd-I, three of the putative [3Fe-4S] Fds balFd-IV, balFd-V and 
balFd-VII, as well as the presumed [2Fe-2S]-containing balFd-X were selected here for more 
detailed biochemical studies. Attempts were made to produce each of the five putative Fds in 
E. coli as a C-terminal His6-tagged recombinant protein. However, only balFd-V and balFd-
VII could be produced efficiently as cofactor-containing proteins. Production of balFd-I and 
balFd-IV in E. coli Rosetta2(DE3)pLysS yielded colorless His6-tagged recombinant proteins, 
lacking the chromophore expected from intact Fe-S clusters. Over-expression of the balFd-X 
gene in E. coli gave no recombinant protein with the expected mass. Further studies on these 
Fds were not pursued here. 
 Production of balFd-V and balFd-VII afforded red-brown-colored holo-proteins that 
were purified by Nickel-NTA and gel filtration chromatography. Each protein eluted from a 
gel filtration column (Superdex 75 10/300 GL, GE Healthcare) with an apparent mass of 
about 24-26 kDa (O'Keefe et al., 1991). Both proteins were ≥90% homogeneous by SDS-
PAGE and analytical reverse phase HPLC, and gave ions consistent with the expected masses 
for the apo-forms by MALDI-MS (for balFd-V m/z = 7826 [M+H]+, calc. 7826.6; for balFd-
VII m/z = 7897 [M+H]+, calc. 7896.6). 
 The recombinant balFd-V and balFd-VII showed broad UV-Vis absorption maxima at 
280-300 nm and 412 nm (Fig. 3), which are typical for oxidized [3Fe-4S] or [4Fe-4S] Fds 
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(Jouanneau et al., 1990; O'Keefe et al., 1991). By comparison, the recombinant His6-tagged 
[2Fe-2S] spinFd showed the expected absorbance maxima at 275, 328, 420 and 463 nm 
(Armengaud et al., 2000). 
 Extinction coefficients for balFd-V and balFd-VII were determined using AAS to 
establish the Fe content, with the assumption that one [3Fe-4S] cluster is present in each 
polypeptide chain (ε412 = 18300 M-1 cm-1 for balFd-V and 14660 M-1 cm-1 for balFd-VII). 
The values found are close to those reported for two Fds from S. griseolus, Fd-1 (ε410 = 
17000 M-1 cm-1) and Fd-2 (ε410 = 20100 M-1 cm-1) (O'Keefe et al., 1991). The quantitation of 
acid labile sulfide was also carried out using a colorimetric assay (Beinert, 1983). Under 
optimized conditions, the assays gave 4.01±0.5 and 3.84±0.5 mol S per mol protein for 
balFd-V and balFd-VII, respectively. 
 
Ferredoxin-mediated reduction of P450 heme iron 
The OxyB P450 enzymes from the vancomycin biosynthetic gene cluster of A. orientalis 
(vanOxyB) and from the balhimycin biosynthetic gene cluster of A. balhimycina (balOxyB) 
were used for CO-binding and activity assays. Upon reduction of the P450 heme iron from 
Fe(III) to Fe(II) using sodium dithionite and exposure to CO, both enzymes showed a 
characteristic Soret absorbance maximum at 450 nm. Following formation of the Fe(II)-CO 
complex, a new species is formed over 1-2 h, absorbing at about 420 nm, the so-called P420 
form, which arises by protonation of the proximal cysteine thiolate ligand of the heme iron 
(Dunford et al., 2007; Perera et al., 2003). 
 CO-binding assays were also performed with each P450 and the primary electron 
transfer proteins ecoFdR and one of spinFd, balFd-V, balFd-VII or ecoFld. These assays 
monitor the ability of each donor to transfer one electron to the P450 heme Fe(III) followed 
by binding of CO to the Fe(II) form. Although the proteins tested have diverse species origins 
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(spinach, E. coli and A. balhimycina) and cofactor types ([2Fe-2S], FMN, [3Fe-4S]), all four 
were able to reduce the Fe(III) heme of vanOxyB, albeit to different extents. The plant spinFd 
rapidly (<6 min) gave up to 75 % conversion (relative to dithionite) to the vanOxyB P450-
form, whereas with ecoFld a maximum of 40 % conversion was reached only after 40 min. A 
fast formation of the P450 from vanOxyB (<10 min) was also observed using either Fd from 
A. balhimycina, with 60 % conversion with balFd-V, and 45% with balFd-VII. 
 The OxyB enzymes from the balhimycin and vancomycin pathways share 88 % 
sequence identity. Nevertheless, some differences were observed between these enzymes in 
their abilities to accept electrons from the four primary redox partners. Thus, balOxyB and 
vanOxyB are both rapidly (<5-6 min) and efficiently (80%) converted into the P450 form by 
spinFd, but the emergence of the P450 form with balFd-V and balFd-VII was slower and 
reached at best 40% (balFd-V) and 20% (balFd-VII) of the response seen with sodium 
dithionite. With balOxyB essentially no reduction was observed using ecoFld. 
 These CO-binding assays do not inform whether or not a second electron transfer can 
occur to the heme as required in the full P450 catalytic cycle. For example, spinFd can donate 
the first electron to camphor-bound P450cam, but allows no hydroxylation of substrate 
(Lipscomb et al., 1976). To address this point, assays were also carried out with peptide 
substrates of OxyB. 
 
Ferredoxin-mediated catalytic activity 
The assay for catalytic activity of OxyB is that described in earlier work (Geib et al., 2008; 
Woithe et al., 2008; Woithe et al., 2007; Zerbe et al., 2004). The substrates used are the 
model hexa- and heptapeptides 1 and 2 (Fig. 1), which are closely related to the expected 
intermediates occurring during glycopeptide biosynthesis. Each peptide is covalently linked 
as a C-terminal thioester to an isolated recombinant PCP domain from the 7th module of the 
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vancomycin NRPS. For ease of synthesis (Li & Robinson, 2005), these model peptides 
contain tyrosine at positions-2 and -6, rather than ß-hydroxy-meta-chlorotyrosine (see Fig. 1). 
Standard conditions were used for all assays, so that a comparison of turnover efficiencies 
could be obtained from the extent of linear peptide conversion into the corresponding 
monocyclic product. The relative amounts of remaining substrate and monocyclic (C-O-D 
ring) product formed were determined after removal of the peptide from the PCP with 
hydrazine, and HPLC and ESI-MS analysis of the corresponding peptide-hydrazides (e.g. the 
hexapeptide hydrazide 3, Fig. 1). 
 The results obtained in assays with vanOxyB and balOxyB are summarized in Table 
2. Intriguingly, all of the electron transfer proteins are able to effectively donate two electrons 
to vanOxyB during the catalytic cycle, using the hexapeptide-PCP (1) as substrate, with 
conversions to monocyclic product (3), under the standard conditions, ranging from 60 to 
over 90%. The heptapeptide-PCP (2, Fig. 1), however, is less efficiently converted into the 
corresponding monocyclic product, with conversions from 10 to 60% observed. It is 
important, however, to note that this heptapeptide substrate (2) is a mixture of inseparable 
diastereomers (which arise during the synthesis of the substrate) differing in configuration at 
C(α) in residue-7. The results also suggest a more favourable interaction between vanOxyB 
and spinFd or balFd-VII, than between vanOxyB and ecoFld or balFd-V. 
 Similar findings were made in activity assays using balOxyB. In this case, however, 
the differences in substrate turnover achieved with the four electron transfer proteins, and 
between the hexa- and heptapeptide substrates, are more pronounced. Assays with balOxyB 
and ecoFld or balFd-V showed only marginal turnover of hexapeptide (1) to monocyclic 
product (3). However, with spinFd and especially with balFd-VII, significant cyclization of 
the substrate was observed (Table 2), with conversion of hexapeptide to monocycle similar to 
that seen in assays with vanOxyB. However, the turnover of heptapeptide (2) was 
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significantly lower, with the best result being 15% conversion to monocyclic product 
achieved with balFd-VII. These results suggest a higher discrimination between the hexa- and 
hepta-peptides, with the hexapeptide being more strongly favored as substrate by balOxyB. 
Finally, these findings also indicate degeneracy in the ability of various different Fds to 
support the catalytic activities of P450 coupling enzymes from different glycopeptide 
producing organisms. This property may well make it difficult to assign a specific function to 
each of the individual Fds identified in the A. balhimycina genome, at least using in vitro 
assays. On the other hand, this flexibility should be an advantage in facilitating more detailed 
in-vitro studies of these interesting cytochrome P450 cross-linking enzymes. 
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TABLES.  
Table 1. Putative ferredoxins identified in the genome of Amycolatopsis balhimycina, 
showing the assigned name and accession number in the EMBL database, predicted number 
of amino acids and type of Fe-S cluster, as well as known ferredoxins showing high sequence 
similarities to each. 
  Significant matches in databases[a] 
Name 
Accession No. 
Amino acids 
(Fd cluster 
type)[b] 
Species Name Protein identifier % identity 
balFd-I 
FN594530 106 (7Fe) 
Mycobacterium smegmatis 
Streptomyces griseus 
FdxA 
7Fe 
gi|151568127 
P13279 
84 
77 
balFd-II 
FN594531 137 (7Fe) 
Mycobacterium smegmatis MC2 155 
Streptomyces coelicolor 
FdxA 
Fdx2 
ABK72965 
NP_629284 
70 
56 
balFd-III 
FN594532 64 (3Fe) 
Saccharopolyspora erythraea 
Streptomyces avermitilis 
FdxB 
FdxB 
CAM02117 
BAC69321 
48 
45 
balFd-IV 
FN594533 62 (3Fe) 
Streptomyces noursei 
Streptomyces nodosus 
NysM 
AmphM 
AAF71770 
AAK73508 
59 
55 
balFd-V 
FN594523 65 (3Fe) 
Streptomyces hygroscopicus 
Streptomyces griseolus 
HbmFdx 
Fd-2 
AAY28236 
P18325 
68 
61 
balFd-VI 
FN594529 76 (3Fe) 
Nocardia farcinica 
Streptomyces nodosus 
Fer 
AmphM 
BAD55984 
AAK73508 
38 
37 
balFd-VII 
FN594528 66 (3Fe) 
Streptomyces griseolus 
Streptomyces noursei 
Fd-2 
NysM 
P18325 
AAF71770 
62 
55 
balFd-VIII 
FN594524 64 (3Fe) 
Streptomyces griseolus 
Streptomyces hygroscopicus 
Fd-2 
HbmFdx 
P18325 
AAY28236 
53 
50 
balFd-IX 
FN594525 63 (3Fe) 
Mycobacterium tuberculosis 
Nocardia farcinica 
FdxD 
Fer 
CAA17740 
BAD55378 
52 
52 
balFd-XI 
FN594527 71 (3Fe) 
Streptomyces peucetius 
Streptomyces avermitilis 
Fdx876 
FdxF 
ACE73825 
NP_827030 
44 
40 
balFd-X 
FN594526 103 (2Fe) 
Rhodococcus sp. RHA1 
Nocardia farcinica 
Fer2 
Fer2 
YP_708187 
YP_119598 
70 
62 
[a] Identified by searching the non-redundant protein sequences (nr) database using each balFd sequence. 
[b] the 7Fe ferredoxins should contain a [4Fe-4S] and a [3Fe-4S] cluster. 
 
Table 2. Activity assays with van and balOxyB using various electron transfer proteins. The 
conversions of substrates 1 and 2 (Fig. 1) into the corresponding monocyclic products are 
shown. 
  Substrate: 1 
Substrate: 
2 
P450 Reduction system Monocyclic product[a] 
Monocyclic 
product[a] 
spinFd / ecoFldR > 90 % ~ 60 % 
ecoFld / ecoFldR ~ 70 % ~ 15 % 
balFd-V / ecoFldR ~ 60 % ~ 10 % 
vanOxyB 
balFd-VII / ecoFldR ~ 80 % ~ 40 % 
spinFd / ecoFldR ~ 45 % ~ 5 % 
ecoFld / ecoFldR < 5 % < 1 % 
balFd-V / ecoFldR < 5 % < 1 % 
balOxyB 
balFd-VII / ecoFldR ~ 75 % ~ 15 % 
[a] Amount of monocyclic hydrazide product formed after one hour as 
determined by HPLC. 
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FIGURES 
Fig. 1. Structures of vancomycin and balhimycin, the substrates (1 and 2) used for assays of 
OxyB, and the monocyclic hexapeptide product (3). 
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Fig. 2. A, sequence comparison of balFd-I and -II, with other known [3Fe-4S][4Fe-4S] (7 Fe) 
Fds. Cys residues that bind the [3Fe-4S] cluster are shown with (*) and those that bind the 
[4Fe-4S] cluster are shown with (). B, sequence comparisons of balFd-V, -VII with other 
known [3Fe-4S] Fds. Cys residues that bind the [3Fe-4S] cluster are shown with (*). C, 
sequence comparisons of balFd-X with other known [2Fe-2S] Fds. Cys residues that bind the 
[2Fe-2S] cluster are shown with (*). Identical residues are shaded gray. 
A 
                             1       *       *                      45 
  A. balhimycina Fd-I    (1) MTYVIAEPCVDVLDKACIDECPVDCIYEGERMLYIHPDECVDCGA 
 A. balhimycina Fd-II    (1) MAYVIGLPCVDVKDRACVAECPTDCIYEGARSLYIHPDECMECGA 
    M. smegmatis FdxA    (1) -TYVIAEPCVDVKDKACIEECPVDCIYEGARMLYIHPDECVDCGA 
M. smeg. MC2 155 FdxA    (1) MTYVIGRPCVDVKDRACVDECPVDCIYEGARMLYIHPDECVDCGA 
       S. griseus Fdx    (1) -TYVIAQPCVDVKDKACIEECPVDCIYEGQRSLYIHPDECVDCGA 
   S. coelicolor Fdx2    (1) MTYVIAQPCVDVKDKACIEECPVDCIYEGQRSLYIHPDECVDCGA 
 
                                *                                      90 
  A. balhimycina Fd-I   (46) CEPVCPVEAIYYEDDVPDNWSDYTKANVDFFDE--------LGSP 
 A. balhimycina Fd-II   (46) CEVVCPVGAVHYEEALPAALREHAPDNGRFFTEVLPGRDAPLGSP 
    M. smegmatis FdxA   (45) CEPVCPVEAIYYEDDVPDQWSSYAQANADFFAE--------LGSP 
M. smeg. MC2 155 FdxA   (46) CEPVCPVEAIYYEDDLPEDLQPYQEENAKFFTDVLPGRAQPLGSP 
       S. griseus Fdx   (45) CEPVCPVEAIFYEDDTPEEWKDYYKANVEFFDD--------LGSP 
   S. coelicolor Fdx2   (46) CEPVCPVEAIFYEDDTPEEWKDYYKANVEFFDE--------LGSP 
 
                             91                                          137 
  A. balhimycina Fd-I   (83) GGASKVGKTAHDPAFIKALPPQGE----------------------- 
 A. balhimycina Fd-II   (91) GGAAAVGPLDADTTMIAALPPQSPPERPLPRKTPRGGGSCCAGERPD 
    M. smegmatis FdxA   (82) GGASKVGQTDNDPQAIKDLPPQGE----------------------- 
M. smeg. MC2 155 FdxA   (91) GGAAKLGVVDADTPMVAELPPQGD----------------------- 
       S. griseus Fdx   (82) GGASKLGLIERDHPFVAGLPPQNA----------------------- 
   S. coelicolor Fdx2   (83) GGASKLGLIERDHPFVAALPPQNQ----------------------- 
 
B 
                              1         *     *                          45 
    A. balhimycina Fd-V   (1) M-KVVVDEEKCCAGGQCVLAAPEVFDQRDEDGVVVLLTANPGPEL 
  A. balhimycina Fd-VII   (1) M-KVTVDEGKCCGAGTCVMLAPDVFDQRDDDGIVILLDERPGEAL 
      S. griseolus Fd-2   (1) M-RIHVDQDKCCGAGSCVLAAPDVFDQREEDGIVVLLDTAPPAAL 
S. hygroscopicus HbmFdx   (1) M-KVSVDQDKCCAAGHCALAAPEVFDQREEDGTVVLLDARPPLEL 
        S. noursei NysM   (1) M-RITVDPGRCVGAGQCVLTAPDLFDQ-DDDGLVTVLAGAADAAD 
       S. nodosus AmphM   (1) MVHVNVDVDRCVGAGQCVLTASDVFDQ-DDDGLVTVLAQPSDPST 
 
                              46        *         67 
    A. balhimycina Fd-V  (45) HEGVREAALICPAAAIALEEA- 
  A. balhimycina Fd-VII  (45) HGVVREAASVCPGVAISVSEDA 
      S. griseolus Fd-2  (45) HDAVREAATICPAAAITVTD-- 
S. hygroscopicus HbmFdx  (45) RDSVAEASFLCPAAAIAVED-- 
        S. noursei NysM  (45) PGDVRDAAALCPSGAISVAAD- 
       S. nodosus AmphM  (46) VETVREAAVVCPSMAITVVEN- 
 
C 
                           1                                      *   45 
A. balhimycina Fd-X    (1) MPKVFYTQPDGAETVIEAVAGDSVMQTAVRNGVSGIVGQCGGVLS 
      P. putida Pdx    (1) MSKVVYVSHDGTRRELDVADGVSLMQAAVSNGIYDIVGDCGGSAS 
   N. farcinica Fdx    (1) MPKVFYTQPDGEVKVVDGAAGDSVMATAVKNGVTGIVGQCGGTLS 
Rhodococcus sp. Fdx    (1) MPKVFYVQPDGVEKVVEGVVGDSVMQTAVRNGVSGIVGQCGGVLS 
 
                           *  *                                     * 90 
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A. balhimycina Fd-X   (46) CATCHVFLAD---GDFPPPGEDEDEMLDCAATEREDNSRLSCQLV 
      P. putida Pdx   (46) CATCHVYVNEAFTDKVPAANEREIGMLECVTAELKPNSRLCCQII 
   N. farcinica Fdx   (46) CATCHVYVDPAEIDRFAEPSEDEDDMLECTSSDRADTSRLSCQLI 
Rhodococcus sp. Fdx   (46) CASCHVFLAADELGNFPEQVEDEEDMLECTAVDREDNSRLSCQLA 
 
                           91            107 
A. balhimycina Fd-X   (88) LAYG-QEVRVTVPEAQL 
      P. putida Pdx   (91) MTPELDGIVVDVPDRQW 
   N. farcinica Fdx   (91) LAEGADDLHVTVPETQA 
Rhodococcus sp. Fdx   (91) LREG-VDVHVTIPDEQL 
 
 
Fig. 3.  UV-Vis absorption spectra of balFd-V (A) and balFd-VII (B) in Tris/HCl buffer (50 
mM, pH 7.5) (solid lines), and after reduction with sodium dithionite (broken lines). 
  
 
 
